mirabegron/solifenacin (Myrbetriq/Vesicare)
Jump to navigation
Jump to search
Indications
- treatment of overactive bladder (FDA-approved May 2018)
More general terms
Components
References
- ↑ Brown T FDA Approves Mirabegron, Solifenacin Combo for OAB. Medscape - May 09, 2018. https://www.medscape.com/viewarticle/896394